Charles Chalfant named program leader of Cancer Cell Signaling
Massey researcher Charles Chalfant, Ph.D., has been appointed as the co-leader of the Cancer Cell Signaling (CCS) research program at VCU Massey Cancer Center. He will serve in this capacity alongside Andrew C. Larner, M.D., Ph.D., who has also co-led the program with Sarah Spiegel, Ph.D., since its inception in 2011.
Combating colorectal cancer: Massey expands its colorectal cancer team, preventative services and treatment options
A variety of factors have contributed to parts of eastern and southern Virginia having some of the highest colorectal cancer death rates in the nation. Massey is working to reverse this trend by expanding it's care team, offering cutting-edge treatment options and working to improve the health of at-risk communities.
Massey pilot study could help identify breast cancer patients who would benefit from preoperative hormone therapy as alternative to chemotherapy
Preliminary findings from a pilot study led by VCU Massey Cancer Center suggest that it may be possible to use genetic testing to identify more breast cancer patients who would benefit from hormone therapy as an alternative to chemotherapy. Hormone therapy, also known as endocrine therapy, lowers estrogen levels or completely restricts estrogen from acting upon breast cancer cells, and its increased use could spare patients from the treatment side effects of chemotherapy and allow for more breast-conserving surgeries.
Massey researcher working to develop novel nanotherapeutics for lung cancer
Scientist Sandro da Rocha, Ph.D., hopes to eventually develop novel drugs that can be used as a primary or adjuvant therapy for multiple forms of lung cancer. A member of VCU Massey Cancer Center’s Developmental Therapeutics research program since March 2016, da Rocha has centered his research on designing nanotherapeutics that can target cancer cells with improved efficacy and decreased toxicity.
Massive community art print honoring locals affected by cancer to be unveiled
A world record-setting print created in September 2016 honoring community members affected by cancer will be unveiled in Richmond, Virginia. This will be the first time the print is on display for public view.